Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03815344 · ClinicalTrials.gov registry record · Phase 4
Combined Vaginal Misoprostol and Perivascular Vasopressin
A Phase 4 study, sponsored by Antonios Likourezos.
- Completed
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
NCT03815344 is a Phase 4 study that has completed, run by Antonios Likourezos. The registered enrollment target is 74 participants.
The verdict
NCT03815344, a Phase 4 study, has completed, sponsored by Antonios Likourezos.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
Study Summary
Injection of Vasopressin into the uterine tissue surrounding fibroids constricts blood vessels, and has been found to be beneficial by decreasing blood flow to fibroids, and thereby resulting in less bleeding with removal. Additionally, Misoprostol has been looked at as an additional method to decrease operative blood loss given its ability to increase uterine muscle tone, which therefore constricts the amount of blood flow to the uterus.
Interventions
- DRUG Standard
- DRUG Standard-vaginal misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2017-04-26 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03815344
The ClinicalTrials.gov registry entry for NCT03815344 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard is the first listed.
NCT03815344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03815344 about?
NCT03815344 is a clinical study titled "Combined Vaginal Misoprostol and Perivascular Vasopressin". Injection of Vasopressin into the uterine tissue surrounding fibroids constricts blood vessels, and has been found to be beneficial by decreasing blood flow to fibroids, and thereby resulting in less bleeding with removal. Additionally, Misoprostol has been looked at as an additional method to decre...
What is the current status of trial NCT03815344?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2017-04-26. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03815344?
The interventions under investigation include: Standard (DRUG), Standard-vaginal misoprostol (DRUG).
Who is sponsoring clinical trial NCT03815344?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.